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Abstract
Background: Motivational abilities (MA), that describe skills in relation to goal-oriented behavior, have recently
been found to be associated with neuropathological aging. Here we examine the impact of MA on the long-term
course of mild cognitive impairment (MCI).
Methods: We followed-up N = 64 individuals diagnosed with MCI (Mage = 73 years, 44% female) for 3 years. MA
were assessed by long-term informants of the participants using two scales: motivation and decision regulation
[Volitional Components Questionnaires, VCQ, (Kuhl and Fuhrmann, Decomposing self-regulation and self-control:
the volitional components inventory, 1998)]. Cognitive abilities were assessed with the Mini Mental State
Examination (J Psychiatr Res 12:189-98, 1975). Survival analyses and multilevel modeling (MLM) were applied to
determine the predicting effect of informant-rated MA at baseline on the likelihood of MCI stability and on the
trajectory of cognitive abilities.
Results: Fifty percent (n = 32) of the MCI participants remained stable, while 32.8% (n = 21) and 17.2% (n = 11)
converted to Alzheimer’s disease (AD) or dropped-out, respectively. Survival analyses revealed that MCI cases with
higher-rated MA at baseline were more likely to exert a stable course in MCI over 3 years (p = 0.036) when
controlling for demographic characteristics and executive function. MLM analyses indicated that higher informant-
rated MA at baseline were significantly related to higher cognitive abilities, even when controlling for MCI subtype
(p = 0.030).
Conclusions: This study provides preliminary longitudinal evidence for a lower risk of conversion to AD and higher
cognitive abilities by higher rated MA at an early stage of MCI.
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Background
Mild cognitive impairment (MCI) is defined as an ob-
jectified decline of cognitive abilities in an individual
over time in at least one cognitive domain, while inde-
pendence with regard to functional abilities prevails and
dementia criteria are not met [1]. Alzheimer’s disease
(AD) dementia is a slowly progressive neurodegenerative
disorder including a gradual cognitive decline in more
than one cognitive domain, most common is the amnestic
syndrome, and in functional abilities of daily living [2]. AD
differs from other dementia by the ‘cause’ of the dementia,
i.e., the underlying pathophysiological changes within the
brain. On a biochemical level, the accumulation of the
amyloid-beta peptide (AB) in the brain has been identified
as a crucial element in the pathology of AD [3].
While in many AD cases, MCI can be identified as a
prodromal syndrome, not all MCI cases progress to AD
or other types of dementia [4]; rather, some cases remain
stable or even revert to previous cognitive performances
(e.g., [5]). However, an increased understanding of why
individuals differ in their stability or progression of MCI,
i.e., what factors predict favorable courses, rather than a
further decrease in cognitive abilities and thus conver-
sion to dementia, would provide crucial indications
about how preventive measures and therapeutic inter-
ventions could best be applied.
This study has been conducted to understand the pre-
dictive role of motivational abilities on the course of
MCI. Given the strong link to current brain and cogni-
tive reserve models, we start with describing these
models in more detail. In a next step, we provide an ex-
tensive definition of motivational abilities, as those build
the basis for the motivational reserve (MR) model. Due
to its relatively new emergence into the scientific litera-
ture, we further describe the MR model and the ration-
ale behind its supposedly protective effect against
cognitive decline. For this, we provide an overview over
previous studies conducted with cognitively intact and
cognitively impaired older adults. Finally, we present our
main research question.
Brain and cognitive reserve and resilience
Dementia progression is characterized by a substantial
interindividual heterogeneity that cannot be sufficiently
explained with disease characteristics [6]. Contextual
factors, including social aspects, psychological and phys-
ical factors have to be taken into account when aiming
to predict progression of dementia [6]. Previous research
indicates that living a physically, socially and intellectually
stimulating and active life may have a protective impact
on the pathophysiological process of MCI and AD (for an
overview see [7]). This phenomenon became known as
the so-called brain or cognitive reserve [8–10]. The cogni-
tive reserve model builds upon the epidemiological
observation that despite the presence of AD neuropathol-
ogy, some older individuals do not show clinical signs of
cognitive impairment (e.g. [11]). Within a new framework
proposed by Arenaza-Urquijo and Vemuri [12] this
phenomenon that has been described as ‘resilience‘to AD,
i.e., normal cognitive functioning despite underlying sub-
stantial AD pathologies (versus ‘resistance‘i.e., normal cog-
nitive functioning without/low underlying substantial AD
pathologies). According to the cognitive reserve model,
the available reserve within the brain (of hereditary or ac-
quired origin, or both) can tolerate or absorb neurodegen-
erative processes before the underlying pathophysiological
process becomes clinically manifested [13]. The higher the
reserve within the brain, the more neuropathology is re-
quired in order to interfere with cognition and functional
abilities [14].
While the brain and cognitive reserve models are cru-
cial in the understanding of interindividual differences in
the susceptibility for developing clinically relevant AD
pathology [14], the current models lack to acknowlegde
factors that influence the “whys” an individual initiates
and carry out those activites in the first place. This ques-
tion relates to motivational abilities, that lie at the bot-
tom of such behavior [15].
Motivational abilities
Motivational abilities are crucial for the understanding
of the trajectory of an individual’s personal and profes-
sional life as they are skills necessary to pursue goals.
The way an individual pursues a particular goal, changes
as a function of age. Several motivational theories exist
that focus on variabilities in goal management over the
life-course, such as the dual-process framework [16], the
model of selection, optimization and compensation [17]
or the life-span theory of control [18].
In general, two different stages can be differentiated in
the pursuit of goals: the stage of selecting a particular goal
(=goal-setting phase) and the stage of goal-striving [19].
For the goal-setting phase, aspects of control and expect-
ancy are needed. A prominent concept related to this is
the self-efficacy concept by Bandura [20] which describes
the strength of belief one has in his or her own capabilities
to deal with life’s challenges. For the goal-striving phase,
aspects of volition and self-regulation are of importance,
such as motivation, decision and activation regulation.
Motivation regulation refers to the ability to keep oneself
motivated when difficulties arise [21]. Decision regulation
describes the ability to make self-congruent decisions [21].
Activation regulation finally is essential to initiate activities
planned to reach a set goal [22]. These regulation pro-
cesses are illustrated by the following hypothetical ex-
ample: decision regulation processes are required when an
individual makes the decision to register for an exam
which is mandatory to graduate from college (=
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self-congruent goal). The repeated process to activate one-
self to study for this exam, rather than spending time with
friends, requires activation regulation processes. To keep
up with the study plan despite adverse circumstances,
such as also having to work night shifts, requires motiv-
ation regulation. Finally, the belief that one can achieve
the set goal despite a potentially unfavorable environment
involves self-efficacy. Together, motivational abilities are
involved in the phases of setting and striving a particular
goal and are of thus integral part of goal-directed human
behavior.
Possible mechanisms underlying the association between
motivational reserve and cognitive trajectories
It follows that motivational aspects are intrinsically con-
nected to activities and behaviors traditionally associated
with cognitive reserve. This notion is supported by pre-
vious empirical work in varying areas. Objective career
success has been found to be meaningfully related to
motivation [23]. Self-motivation, expected benefits,
intention to exercise are all relevant aspects in explaining
“why” an individual engages in physical activity [24]. It
becomes obvious that motivation (‘will’) and cognition
(‘skill’) are both crucial factors for achievements by
self-regulated learning [25]. Given this close link between
the psychological entities of motivation and cognition [26]
“cognitive” activities or behaviors may not be examined in
isolation of motivational abilities that lie at the bottom of
such behavior. Given the intrinsic connection between
motivation and cognition, our research group expanded
existing reserve models with motivation-related aspects
(motivational reserve [MR], [27]).
The basic assumption of the MR model is that motiv-
ational abilities of an individual exert a protective influ-
ence against neuropathological damage. The assumed
underlying mechanism is believed to work in analogy to
the brain or cognitive reserve concepts [8–10, 28]. With
regard to possible mechanisms, current understanding is
that an adequate stimulation of the brain through par-
ticular experiences, training or exercise of certain abil-
ities, such as within the context of education,
occupation or leisure activities throughout the lifespan is
a prerequisite to increase cognitive reserve [14]. The
suggested underlying neural basis discussed hereby are
the enhancement of the interconnectivity of various
brain networks in form of higher efficiency and capacity
and compensatory mechanisms [14, 29]. The increased
use of brain areas specifically related to motivational
abilities is assumed to promote synapse formation and
neuronal growth, which then lead to higher efficiency
within the brain, that in turn allows the compensation of
impaired neuronal networks [30, 31]. For instance,
self-efficacy has been found to predict performances in a
memory task after 6 years in a sample of older adults
[32]. Or internal locus of control, which describes the
confidence that one’s action lead to a particular out-
come, a construct with strong similarities to self-efficacy
[33], were found to be related to the volume of the
hippocampus in older adults [34]. A potentially indirect
mechanism may also be assumed by which motivation
influences the experience of stress, and promotes emo-
tional health or cognition [30, 31].
Previous research on the association between midlife
motivational abilities and cognitive decline
Previous research efforts provided first evidence of a
meaningful association between higher motivational abil-
ities and decreased cognitive decline. In a cross-sectional
study with non-demented individuals of 60-years of age
and older, it was examined whether midlife motivational
abilities, that were estimated on the basis of participant’s
professional history, were related to cognitive status,
well-being and the risk to develop MCI [30]. For this, the
Occupational Information Network (O*Net; [35, 36]) was
used to code all occupations a participant had in his / her
professional life. For each profession, motivational abilities
necessary to conduct the job were rated by two individual
raters (for an extensive description of the exact method,
see [30]). It was found that motivation-related occupa-
tional abilities were related to the risk of MCI, as well as
cognitive status and well-being [30]. This was found even
when factors were controlled that are generally related to
cognitive reserve concepts, such as education and cogni-
tive ability. In a next step, our research group took this
question one step further and examined the same research
question in the context of a prospective study with a lar-
ger (over 2000 older adults) and older (age of 75-years or
older), non-demented sample [31]. It was found that high
motivation-related occupational abilities were related to
reduced risk (− 35%) to develop MCI and AD (in ApoE
epsilon4 carriers only, [31]). These studies provided initial
support that motivational abilities are associated in a
meaningful way with the risk for the development of cog-
nitive decline.
Predictive effect of current motivational abilities on
cognitive decline
It remains unclear whether motivational abilities can be
used to predict the course of existing cognitive decline.
It is assumed that individuals with higher motivational
abilities may exert a more stable course as compared to
individuals with lower motivational abilities due to their
higher reserve.
Palmer and colleagues showed that motivational abil-
ities may still exert a protective influence in the context
of existing cognitive decline [37]. This study was cen-
tered around the syndrome apathy, which includes a lack
of motivation in its set of criteria [38]. The authors
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reported significant increases in the risk for conversion
from MCI to AD in apathetic patients [37].
Goals of the present study
In previous studies, a retrospective estimate of motiv-
ational abilities has been used to examine the potentially
protective effect of motivational abilities on cognitive de-
cline [30]. This retrospective estimate was created by
rating midlife motivational abilities on the basis of a par-
ticipant’s occupational history (O*Net; [35, 36]). While
this method showed to be a valuable approach to esti-
mate midlife motivational abilities, they are nonetheless
indirect measures. In the presence of a lack of assess-
ment of motivational abilities in midlife, which would
have been the optimal measure for the use as predictor,
what are acceptable alternatives? Retrospective assess-
ments suffer from recall biases (e.g. [39]). What is more,
given the reduced abilities of accurate self-judgements in
individuals with cognitive decline [40] current self-reports
of one’s abilities may be less accurate. We therefore chose
informant-rated motivational abilities as predictors for this
study to examine whether they can be used to predict the
long-term course of MCI.
Therefore, we aimed to examine the hypothetically
protective influence of current motivational abilities that
were rated by informants of the participants, on the sta-
bility of MCI. In this study, we focused on the motiv-
ational abilities ‘decision regulation’ (= to decide to do a
specific task) and ‘motivation regulation’ (= to stay with
the task). These two motivational abilities were chosen
as, in contrast to the rather robust self-efficacy ‘belief ’,
they are modifiable and thus well applicable for poten-
tially future intervention. From a content-related as well
as methodological perspective, decision and motivation
regulation belong together and should as such be
assessed in combination, without the additional assess-
ment of other motivation-related constructs (e.g. activa-
tion regulation). We hypothesized that individuals with
higher-rated motivational abilities would exhibit an in-
creased likelihood for stability of MCI, as compared to
MCI individuals with lower informant-rated motivational
abilities, when followed-up for a period of 3 years.
Methods
The data presented here have been sampled in the con-
text of the longitudinal study “Motivational Reserve as a
Protective Factor in Mild Alzheimer’s Dementia and
Mild Cognitive Impairment” (MoReA, [41]).
Study participants
For recruitment and diagnostic purposes, we cooperated
with several different German-speaking Swiss and Aus-
trian memory clinics and specialized institutions for cog-
nitive impairment and dementia. Diagnostic assessments
were conducted by neuropsychologists and medical doc-
tors at the respective institutions, independently, and be-
fore the partaking of the participants in the current
study. In each of the cooperating memory clinics, diag-
noses for participants were made in consensus in an
interdisciplinary team, after an extensive psychiatric,
neurological, clinical and neuropsychological assessment
(see detailed diagnostic assessment below). Inclusion cri-
teria for study participation were as follows: willingness
to partake in the longitudinal study, minimum age of
60 years, and the clinical diagnoses of MCI and mild
AD. For this study, only individuals diagnosed with MCI
were included. Exclusion criteria applied in the
MoReA-study were the diagnosis of a pure vascular de-
mentia or diagnoses of Parkinson’s, Creutzfeld-Jakob’s or
Pick’s disease, as well as traumatic injuries to or previous
surgeries of the brain, as well as neurological diseases or
syndromes such as epilepsy, post-encephalitic or
post-concussional syndromes. Further exclusion criteria
were chronic diseases (such as HIV, metabolic or
hematologic disorders), severe organ failure, history of
malignant diseases or current psychiatric disorders other
than mild AD. Potential participants and their informal
caregivers were informed about the study by the clinical
experts at the specialized clinics and institutions. In case
of expressed interest by the patients to partake in the
study, participants had to complete a written informed
consent at the respective clinic allowing the project
researchers to contact them. Contact details, diagnos-
tic information and neuropsychological data were pro-
vided to the researchers. Together, the memory
clinics referred n = 133 individuals to the study center
(= baseline participation rate). Almost 30% (n = 22)
refused at that stage to participate in the study. Rea-
sons for non-participation were excessive demands
after learning about the diagnosis, or the informants
had no time to take part in the study.
Informants
In order to be able to participate in the study, patients
were required to be accompanied by an informant, i.e., a
reliable source of information. Those informants were
predominantly partners of the participants (70%), children
(17%), or other relatives and friends of the patients (13%).
Most of the informants see the patients on a daily or al-
most daily basis (73.6%) or several times per week (5.7%).
On average, informants know the patients since 46 years
(SD = 14.02), with a range of 6 to 70 years. Written in-
formed consent was obtained from all informants.
Procedure
Baseline assessment (time 1, t1)
A first appointment was arranged with the patients and
their informants, during which in-depth information
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with regard to content and procedure of the study was
provided by the researchers. In the case of persisting
interest, the patients and their informants both provided
written informed consent. During the remaining time of
this first appointment, data collection started, separately
for the patient and the informant, in two different
rooms. Neuropsychological, psychiatric, motivational,
cognitive and socio-demographic information were
assessed during the second part of the first meeting and
completed on a second meeting, an approximately 2.5 h
appointment conducted within the next week.
Follow-ups (t2, t3, t4)
Clinical, neuropsychological and cognitive data were
re-assessed during meetings of approximately 1.5–2 h,
separated by 12-month intervals. Data sampling was ex-
ecuted in a similar fashion as on the baseline assessment
(i.e., separately for the patient and the informal care-
giver). The informal caregiver was interviewed once per
follow-up. All patient interviews over the course of the
3 years were conducted by the same interviewer. This
research assistant has also been the constant contact
person for the patients and informal caregivers. The
interviewer for the informal caregivers varied. For the
assessment at t1, as well as for all follow-ups, partici-
pants were reimbursed with 50 Swiss Francs. The ethics
committees of the Zurich cantonal medical authority ap-
proved the research protocol.
Diagnostic assessment of MCI and AD
An extensive battery of diagnostic instruments for MCI
and AD has been used in the MoReA study (for a
complete overview see, [41]). In the following, we list
those instruments that have been applied in the present
analyses.
Taking into account the international consensus cri-
teria [42], MCI was operationalized in the current study
as following: a) not meeting the DSM-IV criteria for de-
mentia (Mini Mental State Examination, MMSE, score
of 24 points or higher, [43]), b) cognitive decline re-
ported by the patient and / or informant, and / or quan-
tifiable deteriorating cognitive abilities over time, c) no
impairment in basic activities of daily living and only
minimal impairment in complex instrumental functions
(Clinical Dementia Rating Scale, CDR, required score of
0.5 points, [44]) and d) impairment (at least mildly) in
one or more of the subsequent domains: memory, ex-
ecutive function, attention, language and praxis. The cri-
terion for cognitive decline was > 1.5 standard deviation
impairment compared to age and education corrected
norm scores.
The diagnostic criteria given by the Diagnostic and
Statistical Manual of Mental Disorders (DSM-IV-TR,
American Psychiatric Association, [45]) and those of the
National Institute of Neurological and Communicative
Disorders and Stroke-Alzheimer’s Disease and Related
Disorders Association (NINCDS-ADRDA, [2]) were used
for the diagnosis of probable AD. The NINCDS-ADRDA
criteria require a history of cognitive decline and evidence
of impairment in memory and at least one other cognitive
domain. Possible AD cases (in NINCDS-ADRDA termin-
ology) were also included, i.e., persons who met these cri-
teria and also had another condition thought to be
contributing to cognitive impairment. Diagnostic criteria
for AD involved an insidious onset and observable pro-
gression or quantifiable worsening of cognitive impair-
ment (in memory and at least in one other cognitive
domain) and meaningful functional impairment. Mild AD
cases were selected on the basis of a CDR score of 1 [46]
and MMSE score between 18 and 28 points (DSM-IV-TR,
American Psychiatric Association, [45]).
For the assessment of cognitive function, we applied the
Consortium to Establish a Registry for Alzheimer’s Disease
– Neuropsychological Assessment NINCDS-ADRDA,
(CERAD-NP, [44]). The CERAD-NP consists of the
MMSE [43] and an additional 13 measures related to cog-
nitive functioning (for a complete overview see, [41]). To
diagnose and determine the severity of AD, we applied the
widely used, semi-structured CDR interview [44].
Classification of participants into subgroups
The participants that were diagnosed with MCI at both
t1 and all follow-ups until t4 (i.e., those participants that
remained stable with regard to their cognitive decline
throughout the observation period of 3 years), were clas-
sified into the subgroup ‘MCI stability’. Those partici-
pants that converted to (any degree of severity of ) AD
by the assessment at t4, were classified into the group
‘MCI conversion’.
Psychometric assessment of motivational abilities – main
predictor
We further assessed a composite measure of patients’
motivational abilities at baseline (= current motivational
abilities) through informant-ratings of two different
scales for motivation and decision regulation. Two scales
of the Volitional Components Questionnaires (VCQ) [21]
were applied to measure ‘motivation regulation’ (e.g., “I
can usually motivate myself quite well if my determin-
ation to persevere weakens”; Cronbach’s alpha = .87) and
‘decision regulation’ (e.g., “When I think about doing or
not doing something, I usually arrive at a decision
quickly”; Cronbach’s alpha = .69).
The original scales are all constructed as self-report
measures. To receive informant-rated measures, we
reformulated the original items in such a way that the
item can be applied as informant-rated measures (e.g.,
original item “I can usually handle whatever comes my
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way”; re-formulated item “He/she can usually handle
whatever comes his / her way”). There is a small to
moderate correlation between informant and self-rated
motivational abilities [41].
To summarize, a composite measure including two
scales, which were z-transformed beforehand, was cre-
ated for the assessment of the current informant-rated
motivational abilities of the participants.
Additional variables
General information, including living situation, family
status, education, former occupation and health, were
assessed with self-reports. For an extensive description
of former occupation of the sample and how it was
assessed, we refer to Forstmeier and Maercker [41]. Ra-
ther than a measure for physical health in general, we
assessed risk factors with regard to cardiovascular
health, as those have previously been found to mean-
ingfully increase risk for AD (e.g. [47]). We assessed
following factors to calculate a proxy for cardiovascu-
lar risk: diagnosis of diabetes mellitus, diagnosis of el-
evated cholesterol and high blood pressure. Out of
these variables we calculated a composite measure for
cardiovascular risk.
To control for depression, we applied the German ver-
sion of the Geriatric Depression Scale (GDS, [48, 49]).
The Cronbach’s alpha of 0.91 indicates a high internal
consistency [48]. As protective factor, we included edu-
cation (numbers of years of education) as a proxy for
cognitive reserve. To control for the effect of higher or
lower executive functions on MCI stability or conversion
or the trajectory of cognitive abilities, we included the
Stroop-Color Word test [50].
Statistical analyses
All statistical analyses were performed using SPSS for
Mac OSX (22.0) software packages (IBM, Chicago, IL,
USA). Descriptive analyses were used for the calculation
of mean (M) and standard deviation (SD). To assess po-
tential demographic differences between groups, t-tests,
and chi-square tests were applied. Bivariate correlations
were performed to identify relationships between vari-
ables of interest. Little’s missing completely at random
(MCAR) test was conducted to test whether data was
missing in a random way [51]. All data was found to be
MCAR. Multiple imputation was used to address miss-
ing data. The incomplete variables were imputed vari-
able by variable: a filled-in variable is then used as a
predictor in subsequent steps. SPSS automatically used
the monotone method (multiple imputation algorithms).
SPSS applies sequential regression imputation, i.e., linear
and logistic regression for continuous variables and cat-
egorical variables, respectively. Diagnoses of drop-outs
were not imputed. The variables age, sex, MCI subtype,
education (years) had no missing values. The variables
‘motivational abilities’, ‘children’, and ‘cardiovascular risk
factors’ had 1.89, 15.09, and 24.53% missing values, re-
spectively. Analyses of whether conclusions depend on
the imputed variable revealed only minimal differences
between the imputed and non-imputed data set with no
change in the conclusions.
The analytic method of survival analysis using logistic
regression has been chosen to predict which patients are
most likely to stay stable, i.e., keep MCI diagnosis within
the observation period of 3 years [52]. Hosmer and
Lemeshow test results were used to test whether the
models were a good fit for the data. An odds ratio (OR)
lower than 1 is indicative of an increased risk for conver-
sion, while an OR higher than 1 indicates a reduced risk
for conversion. Given the limited power due to the rela-
tive low number of observations and the data reduction
due to dichotomizing into ‘MCI stability’ and ‘MCI con-
version’, we added additional calculations with multilevel
modeling [53]. Multilevel modeling was used to test
whether the trajectory in cognitive abilities, as measured
with the MMSE, can be predicted by informant-rated mo-
tivational abilities. Our sample size for multilevel model-
ing is sufficient for an accurate estimation [54, 55].
Multilevel modeling was conducted with a non-imputed
data set. As a measure of fit, the Akaike information cri-
terion (AIC) was applied. Smaller values in the AIC are in-
dicative of a better fit of a model [53]. For the calculation
of R2 for multilevel modeling, we used calculations pro-
vided by Xu [56]. Data sets for the survival analyses as well
as for the multilevel model were vertically arranged,
resulting in number of observations rather than number
of patients.
All reported results were considered to be significant
at the p ≤ 0.05 level and were considered a trend at the
p ≤ 0.1 level.
Results
Sample characteristics
At t1, the study included n = 64 MCI participants.
Sample characteristics at t1 are shown without the in-
clusion of participants that dropped-out from the
study (n = 11) within the observation period of 3 years
(for sample characteristics at t1, see Table 1).
Drop-out was not related to sample characteristics
(e.g. age, sex), cardiovascular risk, cognitive and mo-
tivational abilities or depression at t1. Reasons for
drop-out from t1 to t2 (n = 7) were: lost interest (n =
4), death (n = 2), and severe somatic illness (n = 1).
Reason for drop-out from t2 to t3 was death (n = 1).
Reasons for drop-out from t3 to t4 were: severe som-
atic illness (n = 1), excessive demand of the testing
situation (n = 1) and not reachable (n = 1).
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Clinical phenotypes of the n = 53 MCI patients at t1
were as follows: amnestic, single-domain (n = 11), amnes-
tic, multi-domain (n = 17), non-amnestic, single-domain
(n = 22), and non-amnestic, multi-domain (n = 3). From t1
to t4, 50% (n = 32) of the MCI participants remained
stable (i.e., they kept their cognitive level), while 32.8% (n
= 21) and 17.2% (n = 11) converted to AD or dropped-out,
respectively (see Table 2). None of the MCI participants
converted back to normal cognitive functioning within the
observation period from t1 to t4.
Table 3 is a correlation matrix of variables used for the
main analyses (see Table 3). It shows that higher age was
significantly related to a higher number of children, to
lower executive function and MCI amnestic subtype.
Female sex was related to higher motivational abilities
and lower education. Higher motivational abilities were
related to fewer years of education (see Table 3).
Comparison of the subgroups of ‘MCI stability’ and ‘MCI
conversion’
In a next step, we compared the basic characteristics of
the ‘MCI stability’ and ‘MCI conversion’ subgroups. We
identified significant differences between these two sub-
groups with regard to age, sex, MCI subtype and num-
ber of children (Table 1). The participants in the ‘MCI
stability’ subgroup were generally younger, of female sex,
of non-amnestic MCI subtype and having fewer
children. With regard to informant-rated motivational
abilities, groups differed significantly with regard to the
composite measure, as well as with regard to motivation
and marginally with regard to decision regulation
(Table 4). Over all these measures, informants rated the
current motivational abilities of the participants in the
‘MCI stability’ group higher as compared to informants
of the participants in the ‘MCI conversion’ group.
Table 1 Sample characteristics at baseline of Mild Cognitive Impairment (MCI) cases, excluding drop-outs (n = 53), and comparison
of basic characteristics between subgroups ‘MCI Stability’ (n = 32) and ‘MCI Conversion’ (n = 21) at last follow-up (t4)
Variables MCI total
(n = 53)
MCI stability
(n = 32)
MCI conversion
(n = 21)
t / χ2-test p d / phi
Age (years), M (SD) 73.09 (7.12) 71.16 (7.61) 76.05 (5.19) 2.57 (t) 0.013 −0.75 (d)
Sex, female, n (%) 26 (49.1) 20 (62.5) 6 (28.6) 5.84 (χ2) 0.016 −0.33 (phi)
Education (years), M (SD) 12.32 (2.52) 12.09 (2.37) 12.67 (2.75) −0.95 (t) 0.346 −0.23 (d)
Living Situation, n (%) 1.79 (χ2) 0.409 0.18 (phi)
- Alone 14 (26.4) 10 (31.3) 4 (19.0)
- Partner 38 (71.7) 21 (65.6) 17 (81.0)
- Family member 1 (1.9) 1 (3.1) 0
Marital status, n (%) 1.54 (χ2) 0.674 0.17 (phi)
- Single 3 (5.7) 2 (6.3) 1 (4.8)
- Married 38 (71.7) 21 (65.6) 17 (81.0)
- Divorced /separated 4 (7.5) 3 (9.4) 1 (4.8)
- Widowed 8 (15.1) 6 (18.8) 2 (9.5)
Children, M (SD) 2.36 (0.88) 2.00 (0.68) 2.89 (0.90) 3.77 (t) < 0.001 −1.12 (d)
MMSE score, M (SD) 27.25 (2.04) 27.69 (2.22) 26.57 (1.54) −1.79 (t) 0.081 0.57 (d)
CDR, M (SD) 0.42 (0.19) 0.39 (0.21) 0.45 (0.15) −1.25 (t) 0.218 −0.33 (d)
GDS-S, M (SD) 2.93 (2.3) 3.34 (2.55) 2.30 (1.97) 1.58 (t) 0.121 0.46 (d)
MCI Subtype, n (%) 11.76 (χ2) 0.008 0.47 (phi)
- Amnestic s-d 11 (20.8) 5 (15.6) 6 (28.6)
- Amnestic, m-d 17 (32.1) 6 (18.8) 11 (52.4)
- Non-amnestic, s-d 22 (41.5) 19 (59.4) 3 (14.3)
- Non-amnestic, m-d 3 (5.7) 2 (6.3) 1 (4.8)
Cardiovascular risk, n (%)
- Diagn. diabetes mellitus 11 (20.8) 9 (28.1) 2 (9.5) 3.64 (χ2) 0.162 0.28 (phi)
- Diagn. elevated cholesterol 15 (28.3) 12 (37.5) 3 (9.4) 2.63 (χ2) 0.105 −0.25 (phi)
- Diagn. high blood pressure 22 (41.5) 16 (50) 6 (28.6) 1.21 (χ2) 0.545 0.16 (phi)
CDR clinical dementia rating scale, d Cohen’s d, Diagn. diagnosis, GDS-S geriatric depression scale – self-report, M mean, MCI mild cognitive impairment, m-d
multi-domain, MMSE Mini-Mental State Examination, n number, p probability, phi Cohen’s phi, SD standard deviation, s-d single-domain, t independent t-test, χ2
chi-square test
The bold values indicate a statistically significant difference with a p-value less than 0.05
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Prediction of MCI stability applying survival analyses
using binary logistic regression
Survival analyses have been conducted using logistic regres-
sion to determine the predictive effect of informant-rated
motivational abilities (= composite measure) at baseline (t1)
on the likelihood of MCI stability (i.e., whether MCI partici-
pants remained stable with regard to their cognitive level
over the course of 3 years). The differential predictive ability
of the single components of the composite measure, i.e.,
motivation and decision regulation were also compared.
Drop-outs were included in these analyses, resulting in n =
138 observations. Observations refer here to the informa-
tion at each of the three follow-ups, of whether MCI pa-
tient remained stable or whether the individual converted
to AD. As soon as the patient converted to AD, no more
observations were added to this particular patient. This im-
plies that if for example a MCI patient remained stable, we
have three observations per patient. See also Table 3 for a
correlation matrix of all included predictors (Table 3).
Model 1
The composite measure consisting of informant-rated
motivation and decision regulation at baseline and the
three follow-up measurement points, were the only pre-
dictors entered in the first model. Given that the model
predicts the probability of MCI stability / conversion
across time, the inclusion of the discrete measurement
points was necessary. The results indicated that the pre-
dictors explained 53.1% (Nagelkerke R2) of the variance.
Higher informant-rated motivational abilities signifi-
cantly predicted MCI stability (OR = 0.59; p = 0.040)
(Table 5). A comparison between the predictive strength
of the two motivational components of the composite
measure indicated that while motivation regulation was
Table 3 Correlation matrix of all predictors included in survival analyses using binary logistic regression and multilevel model
(n = 64)
(1) (2) (3) (4) (5) (6) (7)
(1) Age
(2) Sex (0 =male, 1 = female) −0.20 (0.11)
(3) Number of children 0.29 (0.03) − 0.10 (0.47)
(4) Motivational abilities a − 0.09 (0.48) 0.25 (0.05) 0.04 (0.79)
(5) Executive function b 0.28 (0.03) −0.07 (0.58) 0.14 (0.31) −0.004 (0.97)
(6) Education (years) 0.02 (0.88) −0.33 (0.01) 0.22 (0.11) −0.25 (0.05) − 0.23 (0.07) d
(7) MCI subtype (0 = a; 1 = n-a.) − 0.30 (0.02) 0.21 (0.10) − 0.18 (0.18) − 0.22 (0.09) d − 0.22 (0.09) d 0.10 (0.46)
(8) Cardiovascular risk c 0.24 (0.10) 0.05 (0.76) −0.08 (0.64) 0.11 (0.48) 0.10 (0.50) 0.03 (0.84) 0.17 (0.27)
The bold values indicate a statistically significant correlation with a p-value less than 0.05
a amnestic, MCI mild cognitive impairment, n-a. non-amnestic
a Composite measure including informant-rated motivational abilities at baseline (t1)
b Interference score of the Stroop Color-Word Test
c Composite measure including the diagnosis of diabetes mellitus, elevated cholesterol and high blood pressure
d marginally significant
Values in brackets indicate p-values
Table 2 Number of Mild Cognitive Impairment (MCI) and Alzheimer Disease (AD) cases and drop-outs at baseline and follow-ups in
number (n) and percent (%) (n = 64)
MCI Mild AD Moderate AD Severe AD Drop-out
Baseline (t1) First Follow-up (t2)
MCI (n = 64) 44 (68.8%) 13 (20.3%) 0 (0%) 0 (0%) 7 (10.9%)
First Follow-up (t2) Second Follow-up (t3)
MCI (n = 44) 38 (86.4%) 6 (13.6%) 0 (0%) 0 (0%) 0 (0%)
Mild AD (n = 13) 0 (%) 10 (76.9%) 2 (15.4%) 0 (0%) 1 (7.7%)
Second Follow-up (t3) Third Follow-up (t4)
MCI (n = 38) 32 (84.2%) 4 (10.5%) 1 (2.6%) 0 (%) 1 (2.6%)
Mild AD (n = 16) 0 (%) 11 (68.6%) 2 (12.5%) 1 (6.3%) 2 (12.5%)
Moderate AD (n = 2) 0 (%) 0 (%) 0 (%) 2 (100%) 0 (%)
Baseline (t1) Third Follow-up (t4)
MCI (n = 64) 32 (50%) 15 (23.4%) 3 (4.7%) 3 (4.7%) 11 (17.2%)
AD Alzheimer’s disease, MCI mild cognitive impairment, n number, t1 baseline, t2 first follow-up, t3 second follow-up, t4 third follow-up
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not found to be a meaningful predictor of MCI stability
in this model (OR = 0.97; p = 0.133), decision regulation
did significantly predict MCI stability (OR = 0.96; p =
0.049).
Model 2
In the second model, we added the control variables
‘sex’, ‘age’ and ‘number of children’. Those were all statis-
tically different between subgroups at t1. The results in-
dicated that the predictors explained 63.3% (Nagelkerke
R2) of the variance. It was found that higher
informant-rated motivational abilities marginally pre-
dicted MCI stability, when controlling for these control
variables (OR = 0.52; p = 0.052). Neither ‘age’ (OR = 1.39;
p = 0.323), nor ‘sex’ (OR = 0.59; p = 0.376), but ‘number
of children’ (OR = 1.95; p = 0.028) were identified as sig-
nificant predictors (Table 5). A higher number of chil-
dren was thus associated with a decreased likelihood for
MCI stability over 3 years. A comparison between the
predictive strength of the informant-rated motivation
and decision regulation showed a significant prediction
of MCI stability with both components (motivation
regulation: OR = 2.00; p = 0.042; decision regulation: OR
= 1.95; p = 0.040).
Model 3
In the third model, we additionally included a measure
for executive functions to test whether differences at
baseline executive functions where meaningfully influen-
cing MCI stability. The inclusion of a proxy for ‘execu-
tive function’, i.e., the interference score of the Stroop
Color-Word Test, increased explained variance from
63.3 to 68.7% (R2). ‘Executive function’ was not mean-
ingfully associated with MCI stability (OR = 1.02; p =
0.196). Higher informant-rated motivational abilities sig-
nificantly predicted MCI stability in this model (OR =
0.48; p = 0.036). Again, ‘age’ and ‘sex’ were not meaning-
fully predicting MCI stability, contrary again to ‘number
of children’ (Table 5). While informant-rated
motivational regulation did not predict MCI stability
(OR = 0.97; p = 0.276), ‘informant-rated decision regula-
tion’ did significantly (OR = 0.91; p = 0.008).
Model 4
The fourth model includes, besides the main predictor
of ‘informant-rated motivational abilities’ and the demo-
graphic characteristics, the predictor (years of ) ‘educa-
tion’. ‘Education’ was added to the predictors of Model 2
and not to those of Model 3, as, given the rule of thumb
of 15 observations per predictor, we are at the upper
limit with 8 predictors per model and 138 available ob-
servations. ‘Education’ was included to test whether the
predictive effect of ‘informant-rated motivational abil-
ities’ is reduced when controlling for a proxy of cognitive
reserve. The predictors explained a variance of 62.4%
(R2) in this model. ‘Education’ was not found to be
meaningfully related to MCI stability (OR = 0.97; p =
0.804). Higher informant-rated motivational abilities
marginally predicted MCI stability in this model (OR =
0.52; p = 0.051) (Table 5). Again, as in Model 3: while
informant-rated motivational regulation did not predict
MCI stability (OR = 0.97; p = 0.258), informant-rated de-
cision regulation did (OR = 0.92; p = 0.021).
Model 5
The fifth model includes, besides the main predictor of
‘informant-rated motivational abilities’ and the demo-
graphic characteristics, the predictor ‘MCI subtype’. We
added ‘MCI subtype’ as predictor in addition to those in-
cluded in Model 2 (and not to Model 3 or Model 4), due
to a limited number of available observations. ‘MCI sub-
type’ was added as predictor as the clinical phenotype
‘MCI amnestic’ is commonly related to a higher conver-
sion rate. Due to an unequal distribution of participants
to the four MCI phenotypes, we combined the two
amnestic and the two non-amnestic subtypes each into
one group, resulting in a dichotomous MCI subtype
variable (amnestic / non-amnestic). The inclusion of
Table 4 Informant-rated motivational abilities for all Mild Cognitive Impairment (MCI) cases at baseline (n = 53) and comparison of
informant-rated motivational abilities between the subgroups ‘MCI Stability’ and ‘MCI Conversion’ as diagnosed at last follow-up (t4)
Motivational abilities a MCI total
(n = 53)
MCI stability
(n = 32)
MCI conversion
(n = 21)
t-test p d
Composite measure, min-max, M (SD) 2–14.5 3–14.5 2–11 2.31 0.025 0.665
8.48 (2.88) 9.21 (2.93) 7.40 (2.50)
Motivation regulation, min-max, M (SD) 2–15 2–15 2–11 2.23 0.030 0.654
8.37 (3.24) 9.16 (3.53) 7.19 (2.38)
Decision regulation, min-max, M (SD) 0–15 0–15 2–12 1.92 0.061 b 0.545
8.60 (3.10) 9.26 (3.10) 7.62 (2.91)
d Cohen’s d, M mean, max maximum, min minimum, n number, SD standard deviation, t independent t-test
a Composite measure including informant-rated motivational abilities at baseline (t1)
b marginally significant
The bold values indicate a statistically significant difference with a p-value less than 0.05
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Table 5 Survival analyses using binary logistic regression predicting likelihood of Mild Cognitive Impairment (MCI) stability (coded as
1) (n = 64)
Variable B SE P Value OR 95% CI
Model 1
Follow-up 1 −1.24 0.66 < 0.001 0.289 0.153–0.546
Follow-up 2 −1.85 0.59 < 0.001 0.157 0.065–0.379
Follow-up 3 −1.78 0.56 < 0.001 0.168 0.064–0.436
Motivational abilities a −0.53 0.36 0.040 0.587 0.353–0.976
Model 2
Follow-up 1 −0.52 0.92 0.572 0.596 0.099–3.582
Follow-up 2 −1.85 1.05 0.078 c 0.157 0.020–1.233
Follow-up 3 −0.76 1.01 0.454 0.468 0.064–3.413
Motivational abilities a −0.65 0.33 0.052 c 0.524 0.273–1.005
Age 0.33 0.33 0.323 1.389 0.725–2.661
Sex (0 =male, 1 = female) −0.53 0.60 0.376 0.589 0.182–1.902
Children (number) 0.67 0.30 0.028 1.954 1.076–3.547
Model 3
Follow-up 1 −1.07 1.02 0.294 0.345 0.047–2.519
Follow-up 2 −2.34 1.13 0.038 0.096 0.011–0.880
Follow-up 3 −1.27 1.10 0.247 0.280 0.032–2.414
Motivational abilities a −0.74 0.35 0.036 0.477 0.239–0.952
Age 0.13 0.36 0.727 1.135 0.558–2.308
Sex (0 =male, 1 = female) −0.54 0.60 0.372 0.584 0.179–1.902
Children (number) 0.73 0.32 0.022 2.082 1.109–3.908
Executive function b 0.02 0.01 0.196 1.016 0.992–1.042
Model 4
Follow-up 1 −0.11 1.89 0.955 0.899 0.022–36.773
Follow-up 2 −1.46 1.91 0.446 0.233 0.005–9.854
Follow-up 3 −0.35 1.93 0.854 0.702 0.016–30.550
Motivational abilities a −0.66 0.34 0.051 c 0.515 0.264–1.003
Age 0.31 0.34 0.374 1.358 0.692–2.667
Sex (0 =male, 1 = female) −0.58 0.64 0.360 0.559 0.161–1.940
Children (number) 0.70 0.32 0.031 2.003 1.066–3.763
Education (years) −0.03 0.11 0.804 0.973 0.781–1.212
Model 5
Follow-up 1 −0.07 0.96 0.940 0.930 0.141–6.120
Follow-up 2 −1.36 1.09 0.213 0.257 0.030–2.181
Follow-up 3 −0.17 1.07 0.876 0.845 0.103–6.941
Motivational abilities a −0.63 0.33 0.060 c 0.534 0.277–1.028
Age 0.16 0.38 0.684 1.169 0.551–2.479
Sex (0 =male, 1 = female) −0.45 0.62 0.470 0.638 0.188–2.161
Children (number) 0.73 0.33 0.024 2.084 1.100–3.947
MCI amnestic (0 = amnestic, 1 = non-amnestic) −1.47 0.62 0.018 0.230 0.068–0.773
Model 6
Follow-up 1 −0.79 1.45 0.584 0.452 0.026–7.749
Follow-up 2 −1.35 1.64 0.408 0.258 0.010–6.381
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‘MCI subtype’ increased explained variance from 63.3 to
66.1% (R2). The clinical phenotype ‘MCI amnestic’ was
found to be associated with a decreased likelihood for
MCI stability over 3 years (OR = 0.23; p = 0.018). The
informant-rated motivational abilities marginally pre-
dicted MCI stability in this model (OR = 0.53; p =
0.06) (Table 5). While informant-rated motivational
regulation did not predict MCI stability (OR = 0.97; p
= 0.296), informant-rated decision regulation did (OR
= 0.93; p = 0.021).
Model 6
We additionally calculated Model 2 by adding a proxy for
‘cardiovascular risk‘. The predictors in this model ex-
plained 80% of the variance (R2). The variable ‘cardiovas-
cular risk‘was associated with a decreased likelihood for
MCI stability over 3 years (OR = 0.04; p = 0.038). The
informant-rated motivational abilities did not predict MCI
stability in this model (OR = 0.61; p = 0.303) (Table 5), nei-
ther did the informant-rated motivational regulation (OR
= 0.96; p = 0.384) nor the informant-rated decision regula-
tion (OR = 0.96; p = 0.249).
Multilevel modeling
At first, we calculated whether the proportion in the
variance of cognitive abilities, as measured with the
MMSE, indicated the need for analyses with multilevel
modeling. The intraclass correlation (ICC) was 43.90%,
indicating that around 44% of the total MMSE variance
resides between patients and around 56% within patient’s
repeated measures. The relatively large ICC indicates
that data can be analyzed by multilevel modeling [53].
We found a significant between individual variance
(Wald Z = 4.22, p < 0.001), indicating significant variation
in the intercepts of MMSE (= random intercept; AIC =
1177). We also found a significant variation in the slope
of MMSE between participants (= random slope; AIC =
1067; Wald Z = 4.33; p < 0.001). As of that, further ana-
lyses were conducted using the random intercept,
random slope model. Additionally, we calculated the
model with quadratic time to test for curvilinearity in
the trajectory of MMSE. The effect was not significant
(p = 0.113). Consequently, we calculated our models with
linear time only.
In order to provide comparative analyses to the sur-
vival analyses models using logistic regression above, we
calculated the multilevel models without interaction ef-
fects. Nonetheless, interaction effects of time with all
predictors were calculated for all models (data not
shown). The addition of interaction effects did not result
in increasing the model fit as indicated by the model fit
index AIC.
Model 1
In the first model, we were interested in the main effect
of ‘informant-rated motivational abilities’ on the trajec-
tory of cognitive abilities over a three-year observation
period. As of that, we included only time and ‘informan-
t-rated motivational abilities’ into the first model. We
found a significant negative main effect of ‘time’ (t = −
3.08; p = 0.002) and significant positive effect of ‘infor-
mant-rated motivational abilities’ (t = 2.33; p = 0.023) on
the trajectory of cognitive abilities.
Model 2
In a second model, we added the demographic charac-
teristics ‘age’ and ‘sex’. Unlike the survival analyses, we
did not add ‘number of children’ in these models, as
current literature is not suggestive of a protective influ-
ence of having fewer children on the course of cognitive
abilities. Again, we found a significant negative main ef-
fect of ‘time’ (t = − 3.08; p = 0.002). In addition, we found
a marginal positive effect of ‘informant-rated motiv-
ational abilities’ (t = 1.95; p = 0.056). The effect of the
demographic characteristics ‘age’ (t = − 1.21; p = 0.231)
and ‘sex’ (t = 1.54; p = 0.129) were not significant.
Table 5 Survival analyses using binary logistic regression predicting likelihood of Mild Cognitive Impairment (MCI) stability (coded as
1) (n = 64) (Continued)
Variable B SE P Value OR 95% CI
Follow-up 3 −0.14 1.58 0.931 1.146 0.052–25.359
Motivational abilities a −0.50 0.49 0.303 0.606 0.233–1.574
Age 0.78 0.52 0.135 2.181 0.784–6.064
Sex (0 =male, 1 = female) −0.38 0.92 0.683 0.687 0.113–4.163
Children (number) 0.90 0.48 0.060 c 2.455 0.963–6.255
Cardiovascular risk factors −3.29 1.59 0.038 0.037 0.002–0.837
The bold values indicate a statistically significant correlation with a p-value less than 0.05
B coefficient, CI confidence interval, MCI mild cognitive impairment, OR odds ratio, p level of significance, SE standard error
a Composite measure including informant-rated motivational abilities at baseline (t1)
b Interference score of the Stroop Color-Word Test
c marginally significant
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Model 3
In the third model, we included a proxy for ‘executive
function’. We found a significant negative main effect of
‘time’ (t = − 3.28; p = 0.002), a significant positive effect
of ‘informant-rated motivational abilities’ (t = 2.32; p =
0.023), and a significant negative effect of the interfer-
ence score of the Stroop Color-Word test (t = − 3.03; p
= 0.004), which can be translated into a significant posi-
tive effect of ‘executive functions‘. ‘Age’ (t = -0.59; p =
0.558) and ‘sex’ (t = 1.64; p = 0.106), were again not sig-
nificant in this model.
Model 4
In the fourth model, we included a proxy for cognitive
reserve, i.e., years of ‘education’. We found a significant
negative main effect of ‘time’ (t = − 3.28; p = 0.002), a sig-
nificant positive effect of ‘informant-rated motivational
abilities’ (t = 2.36; p = 0.022), and a significant negative
effect of the interference score of the Stroop
Color-Word test (t = − 2.80; p = 0.007), which, again, can
be translated into a significant positive effect of ‘execu-
tive functions‘. ‘Age’ (t = -0.59; p = 0.560) and ‘education’
(t = 0.40; p = 0.689) were not significant, and ‘sex’ only
marginally (t = 1.68; p = 0.098).
Model 5
In the final model, we additionally included ‘MCI sub-
type’. We found a significant negative effect of ‘time’, a
significant positive effect of ‘informant-rated motiv-
ational abilities’, a significant negative effect of the inter-
ference score of the Stroop Color-Word test, i.e.,
significant positive effect of ‘executive functions‘(see
Table 6). The R2 estimate for this final and best fitting
model is 41.03.
Additional analyses
We also compared the predictive strength of informant-rated
motivation and decision regulation in Model 5. We found
that while ‘motivation regulation’ was not a meaningful pre-
dictor (t= 0.92; p= 0.361), ‘decision regulation’ had a signifi-
cant positive effect on cognitive abilities in this model (t=
3.03; p= 0.004). Also, we added the predictor ‘depression’ to
Model 5 in order to control for influences of depressive men-
tal states. ‘Depression’ predicted cognitive abilities signifi-
cantly (t= 2.10; p= 0.04). Motivational abilities remained a
significant predictor in this model (t= 3.23; p= 0.002). Fi-
nally, we added a proxy for health (‘cardiovascular risk’) to
Model 5 in order to control for the effect of health. While
the measure for ‘cardiovascular risk’ did not significantly pre-
dict cognitive abilities (t= 1.30; p= 0.201), the inclusion of
this somatic risk factor decreased the predictive ability of
‘informant-rated motivational abilities’ to a non-significant ef-
fect (t= 1.15; p= 0.259).
Figure 1 illustrates the differential trajectories of indi-
viduals with high and low decision regulation, as calcu-
lated with median split, over the four measurement time
points with regard to their performances in the MMSE
(Fig. 1).
Discussion
Here we aimed to examine the hypothesized protective
influence of motivational abilities on the course of MCI.
In the context of a longitudinal, prospective study, we
compared the predictive effect of informant-rated
Table 6 Growth model parameter estimates of predictors for trajectories in cognitive abilities, as measured with the Mini Mental
State Examination (MMSE) (n = 64)
Variable MMSE
Fixed effects Random effects
Estimate (s.e.) df t p Variance Co-Variance
Intercept 26.11 (0.71) 63.73 26.80 0.001 1.26 −0.45 a
Time (years) − 0.82 (0.25) 54.74 −3.29 0.002 2.96 −0.45 a
Motivational abilities b 0.56 (0.25) 60.90 2.23 0.030
Age −0.11 (0.23) 64.39 −0.49 0.623
Sex (0 = male, 1 = female) 0.76 (0.48) 61.83 1.58 0.120
Executive function c − 0.62 (0.22) 60.85 −2.78 0.007
Education (years) 0.08 (0.24) 62.15 0.32 0.751
MCI subtype (0 = amnestic, 1 = non-amnestic) 0.16 (0.47) 62.92 0.35 0.731
Residual 2.57
AIC = 1047.86
The bold values indicate a statistically significant correlation with a p-value less than 0.05
AIC Akaike information criterion, df degrees of freedom, MMSE Mini-Mental State Examination, p probability, s.e. standard error, t independent t-test
a Covariance of the Intercept and Time random effects
b Composite measure including informant-rated motivational abilities at baseline (t1)
c Interference score of the Stroop Color-Word Test
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motivational abilities measured at baseline on the likeli-
hood of MCI stability over a time period of 3 years. Our
main finding was that informant-rated motivational abil-
ities were meaningful predictors of MCI stability, even
when controlling for demographic characteristics, ex-
ecutive functions at baseline or MCI subtype (i.e.,
amnestic vs. non-amnestic). The analyses conducted
with logistic regression were partly supported by ana-
lyses using multilevel modeling. A comparison of the
predictive strength of motivation versus decision
regulation suggests that the potentially protective ef-
fect of motivational abilities may mainly be driven by
the motivational ability ‘decision regulation’. However,
the control for the influence of cardiovascular risk at
baseline resulted in the disappearance of a meaningful
effect of motivational abilities. Given the relatively
small sample size and the related low statistical
power, in addition to the occasionally only marginally
significant findings, our results may be considered as
preliminary.
In our sample, we observed a conversion rate from
MCI to AD of 32.8%. Given the relative short observa-
tion window of 3 years, this rate can be considered as
comparatively high [4]. Previous studies have indicated
that individuals who seek professional help due to their
memory impairments [57], as well as individuals who
complain about their memory loss [58], are at a higher
risk for conversion. Given that we were recruiting our
participants in specialized clinics and institutions, as well
as by advertisements, we might have recruited individ-
uals at a higher risk for conversion.
Our preliminary finding of a meaningful prediction of
MCI stability by informant-rated motivational abilities
corroborates previous cross-sectional [30] and prospect-
ive findings [31]. Given that in both previous studies, an
indirect measure of motivational abilities (i.e., an esti-
mate for motivational abilities that is based on the main
occupation the individual had in midlife, by applying the
O*NET, see description in [30, 31, 41, 59]) was used to
predict MCI courses, we could extend those finding by
showing that informant-rated motivational abilities can
be used to predict MCI courses. We re-calculated all
analyses with self-rated motivational abilities (data not
shown). We found that self-rated motivational abilities
are not effective in predicting the course of MCI stabil-
ity. This corresponds to findings by Snow and col-
leagues, who concluded that self-reports of individuals
with cognitive decline may be less accurate due to a di-
minished awareness [40].
On the basis of our analyses, it appears as if the motiv-
ational ability ‘decision regulation’ may be more closely
related to MCI stability and cognitive abilities as com-
pared to ‘motivation regulation’. Decision regulation
may be linked to the actual behavioral decision-making
process. A recent longitudinal study with non-demented
older adults (mean age of 83.5 years) found that poor
Fig. 1 Trajectories in performances in Mini-Mental State Examination (MMSE) over the four measurement time points for individuals with high
and low informant-rated decision regulation, computed with median split
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decision-making reflected deteriorating cognitive abil-
ities [60], rather than predicting cognitive decline. The
authors concluded that their results “..suggest that even
very subtle age-related changes in cognition have detri-
mental effects on judgment.” [60]. As a consequence, it
may be that in the current study, differences in the in-
formant ratings of decision regulation may reflect subtle,
indirect judgments of cognitive decline, more so than
differences in motivation regulation.
The predictive ability of motivational abilities disap-
peared when controlling for the influence of cardiovas-
cular risk factors. It can be assumed that cardiovascular
risk might act as a mediator between motivational and
cognitive abilities by translating motivational abilities
into beneficial health outcomes. For instance, higher
motivated individuals may engage more in activities that
are promoting cardiovascular health, such as the in-
creased engagement in physical activities, which are
known to exert a beneficial effect on cognitive health in
older age (e.g. [61]). How can it be explained that motiv-
ational abilities predict a more benign course of MCI?
Analogous to the brain or cognitive reserve concepts
[8–10, 28], we propose the motivational reserve concept,
based upon the assumption that the increased use of
certain brain areas promotes synapse formation and
neuronal growth, which lead to higher efficiency within
the brain, that in turn allows the compensation of im-
paired neuronal networks. By an increased activation of
brain areas directly related to motivational abilities, such
as the prefrontal cortex, the nucleus accumbens and the
amygdala [62, 63], or indirectly related by the influence
of motivation on stress, emotional health or cognition
[30, 31], those areas become more efficient and are thus
able to compensate for affected networks through brain
plasticity. Our preliminary findings support the predic-
tions drawn from the motivational reserve model by
showing that higher motivational abilities at an early
stage of MCI may exert a protective influence on the
course of MCI. Future studies are needed to investigate
the underlying mechanims (e.g. potential mediation by
health behavior tendencies) in the translation of motiv-
ational abilities into better health outcomes in later life.
An unexpected finding was the meaningful, negative
association between motivational abilities and education,
as it was expected that a higher level of motivational
abilities would be related to higher educational achieve-
ments (i.e., more years of education). When controlling
for the impact of gender, this association disappears. The
control for the influence of gender might in fact be rele-
vant with regard to this relation: on one hand, in our
sample, female gender was related to higher motivational
abilities. On the other hand, Swiss women of the gener-
ation of our sample (cohorts 1930–1960) did not gain
the same access to higher education as their male
counterparts. This is also reflected in the significant dif-
ference in years of education between male and female
participants. As of that, it may be that a (social) gender
bias within our older sample might have obscured the
expected meaningful association between motivational
abilities and (years of ) education.
A further unexpected finding of our study was the re-
sult of a lower risk for MCI conversion in individuals
having fewer children. Given the fact that we included
this variable as a control variable due to a significant dif-
ference between the two MCI subgroups, this inclusion
was not led by theory. To the best of our knowledge, this
finding is unprecedented. A higher number of children
is an indirect indicator of lower parental intelligence
[64] and socio economic status (SES). Thus, we specu-
late that those individuals having more children may
have less protection against cognitive decline, as higher
intelligence and SES have a preventive influence on
pathological cognitive decline [9, 10, 65]. However, our
data did not reveal a meaningful relation between num-
ber of children and intelligence or years of education (as
a proxy for SES), neither for men nor women (all corre-
lations are non-significant, data not shown). Another,
though highly speculative explanation, may be found in
the life history theory (LHT), that states that increased
reproductive effort (i.e., a higher number of offspring),
might come at the expense of tissue maintenance and
thus accelerate aging [66]. For instance, in a study in-
cluding older women (mean age of 75 years), it was
found that a higher number of children was associated
with shorter telomere length [67], a proxy for cellular
aging that has previously been linked to dementia risk
[68]. However, a recent, prospective study did not find a
meaningful association between the number of children
and maternal telomere length. Rather, mothers with
fewer children had even shorter telomere lengths [69].
Again, this explanation is highly speculative and more
research is needed to understand the unexpected finding
in our study that a greater number of children was asso-
ciated with higher risk for MCI conversion.
Our findings must be interpreted in the light of the
following limitations. A limiting factor of our study is
the use of current motivational abilities that have been
rated by informants of the participants. The assessment
of current motivational abilities is flawed by the fact that
it can be argued that lower current motivational abilities
may be an early sign of an underlying neuropathological
process rather than a premorbid risk factor. In fact,
pathological cognitive decline seems to impact motiv-
ational abilities. For instance, in an own study, we were
able to show that individuals with mild AD displayed
higher rates in the motivational construct ‘delay dis-
counting’ over an observation period of 2 years which
indicates decreasing self-control with progressive
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cognitive decline [70]. Brain areas related to motiv-
ational abilities, such as the prefrontal cortex, the nu-
cleus accumbens and the amygdala [62, 63] can all be
affected by AD neuropathological processes. It is as such
a possibility that lower motivational abilities in our study
do reflect some sort of cognitive decline. However, this
may not completely undermine our hypothesis of a pro-
tective effect of higher motivational abilities on the
course of MCI, as higher levels of motivational abilities
may still act as a buffer against cognitive decline, even
when impairment has already begun. Nonetheless, we
may not completely exclude the argument that lower
current motivational abilities reflect early AD disease
processes.
The optimal predictor with regard to the research
question of interest may have been the direct assessment
of motivational abilities during midlife, i.e., decades
before the first clinical signs of cognitive impairment ap-
peared. Given that this was not feasible in the current
study, other possibilities (besides the indirect assessment
through estimates of motivational abilities on the basis
of participants’ occupational history, see [30]), were ei-
ther the retrospective assessment, which, however, is
flawed by recall bias, or the use of the rating by infor-
mants, which, as we were able to show in a previous
study, can be biased by the caregiving burden [71].
A further essential limiting factor is the small sample
size of our study, particularly with regard to the regres-
sion analyses. Those results have to be interpreted with
caution. Due to the small sample size and the related
low statistical power [72], it is both likely that we did
not find significant effects of factors that were previously
identified as risk (MCI subtype) or protective factors
(i.e., education). It is also likely that due to the small
sample size our significant finding of a protective effect
of motivational abilities on the course of MCI may not
mirror a true effect [72], i.e., could have been an over-
estimation. In combination, i.e., due to the fact that our
independent variable might have been affected by on-
going underlying disease processes, in combination with
the small sample size, the external validity of our find-
ings is limited, and interpretations of our results should
be done with caution.
What is more, we did not assess the time point of
when the diagnoses of the patients were made for the
first time, which could have been used as a standardized
proxy of the onset of the clinical symptoms of MCI.
While most of our participants were diagnosed in the
months before recruitment for the study, we have no in-
formation with regard to how long MCI symptomatol-
ogy persisted before participants presented themselves
to a clinician and were then diagnosed with MCI. It
could therefore be that patients with stable courses were
those with the most recent onset of MCI. But given the
fact that the pre-clinical biological changes related to
AD might take years to decades before the clinical phase
of AD [73], any ‘starting point’ could only ever be
vaguely defined. Nonetheless, future studies should in-
clude duration of the clinical manifestation of the symp-
tomology as a proxy. Future studies should also include
the assessment of biomarkers, to increase the level of
certainty of the AD diagnosis [2]. Also, the assessment
of AB protein would have been useful as it has previ-
ously been proposed that AB negative MCI cases are un-
likely to progress to AD [1]. Furthermore, our measure
for ‘health’, i.e., a proxy for cardiovascular health, is lim-
ited. Future studies should include a broader indicator for
physical health. Additionally, it is to be assumed that the
participants (and their informants) show self-selection
bias. Taking part in a relative extensive longitudinal study
while being diagnosed with MCI may itself be a sign for
higher motivational abilities. Therefore, it may be that our
results are biased towards higher motivated, research in-
terested participants, which might have affected our study
on various levels (e.g. recruitment, data collection) and
might thus reduce validity of our results. Also, the assess-
ments of the diagnoses at follow-ups were carried out by a
group of clinicians that might involve the same or other
persons that carried out the diagnoses at baseline. How-
ever, this group of clinicians was not involved in the as-
sessment of affective and motivational variables. It was
strived for having the group of clinicians blinded for the
previous MCI and AD diagnoses, however, this could
not have been guaranteed for all participants. Finally,
the observation period of 3 years is relatively short. It
is thus of importance to replicate our findings in a
study with a larger sample size that is followed up for
a longer period of time.
Conclusions
Bearing in mind the preliminary nature of our results,
this study provides first evidence for a protective ef-
fect of motivational abilities on the course of MCI.
Given the modifiable nature of motivational abilities,
future studies should investigate how those skills may
best be trained in coaching courses, how they might
be integrated into existing psychotherapeutic manuals
for both older and younger individuals and whether
such interventions are effective in increasing cognitive
health in older age [31].
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